Rainbow
Latest round
- Series B
Last raised
- Sep 2023
Total raised
- $3.2M
Investors
- 6
About Rainbow
Based in Japan, Rainbow Inc.Founded in 2019 in Sapporo-shi, Japan, Rainbow Inc. specializes in regenerative medicine, particularly through its lead product HUNS001.RAINBOW specializes in the development and commercialization of regenerative medicine products, focusing on HUNS001, a therapy for chronic conditions like stroke.RAINBOW generates revenue through partnerships with healthcare institutions and clinical trials, establishing B2B relationships with hospitals and healthcare providers to utilize HUNS001.In September 2023, Rainbow Inc. The company plans to launch new products and expand into additional Asian markets, focusing on addressing specific medical conditions that currently lack effective treatments.
Who invested in Rainbow
6 investors across 2 rounds
See all investors in Rainbow
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rainbow
Who invested in Rainbow?
Rainbow has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rainbow raised?
Rainbow has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rainbow last raise money?
Rainbow's most recent round on record is a Series B, in Sep 2023.
What does Rainbow do?
Rainbow is a biotechnology company.
Where is Rainbow headquartered?
Rainbow is headquartered in Sapporo-shi, Japan.
Which VCs invest in companies like Rainbow?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Rainbow's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Rainbow? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.